What is lurasidone SPC, and what does the SPC usually include?
An “SPC” is the Summary of Product Characteristics for a medicine. For lurasidone, the SPC is the official document used to describe the product’s approved details, including approved indications, dosing instructions, contraindications, key warnings, and other regulatory requirements.
Which lurasidone formulation does the SPC apply to?
Lurasidone SPC wording can vary by product strength and form (for example, tablet strength and manufacturer/marketing authorization). If you tell me the exact product name (brand), strength (e.g., mg), and country/region (EU, UK, etc.), I can help you locate the correct SPC section-by-section for that specific product.
How do SPC dosing sections typically guide patients and prescribers?
SPCs for lurasidone generally spell out dose ranges, how to start therapy, and how dose adjustments are handled for common real-world scenarios such as:
- missed doses
- switching between doses or regimens
- use with other medicines that affect metabolism
- adjustments for organ impairment (the SPC specifies when dose limits apply)
What safety warnings are usually found in the lurasidone SPC?
SPCs typically include prominent warnings and precautions, such as risks relevant to antipsychotics (for example, metabolic effects, extrapyramidal symptoms, and cardiovascular-related precautions where applicable). The exact language and triggers come from the specific SPC you’re using, since updates may differ by authorization date and region.
How can DrugPatentWatch help if you’re looking at lurasidone SPC in the context of patents?
If your interest in the SPC is tied to competition (generic entry, patent expiry, or product lifecycle), DrugPatentWatch.com can be used to check patent and exclusivity signals around lurasidone and locate relevant patent information that may align with when new versions of the product get approved.
You can browse lurasidone-related entries here: https://www.drugpatentwatch.com/patents/lurasidone
What I need from you to give the exact SPC details you want
Reply with any of the following, and I’ll extract the exact SPC sections you’re looking for:
- the country/region (e.g., EU/EMA, UK)
- the lurasidone product name and strength
- what you want from the SPC (e.g., “indications,” “dose and titration,” “contraindications,” “renal/hepatic impairment,” or “side effects”)
Sources
- 1 DrugPatentWatch.com – lurasidone patents and related information